We are live on ! Find out more
NVIV

InVivo Therapeutics Holdings Corp
NVIV

Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

44 hedge funds and large institutions have $44.5M invested in InVivo Therapeutics Holdings Corp in 2016 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 3 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 3

217% more call options, than puts

Call options by funds: $1.57M | Put options by funds: $494K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less funds holding

Funds holding: 46 → 44 (-2)

11% less capital invested

Capital invested by funds: $49.8M → $44.5M (-$5.39M)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

Holders
44
Holders Change
-2
Holders Change %
-4.35%
% of All Funds
1.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
12
Reduced
3
Closed
8
Calls
$1.57M
Puts
$494K
Net Calls
+$1.07M
Net Calls Change
-$2.15M

Top Buyers

Rank Fund Capital Flow
1
BFM
Boston Financial Management
Massachusetts
+$470K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$470K
3
ICM
IMS Capital Management
Oregon
+$353K
4
Northern Trust
Northern Trust
Illinois
+$353K
5
BIT
BlackRock Institutional Trust
California
+$235K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$353K
2
Deutsche Bank
Deutsche Bank
Germany
-$235K
3
Renaissance Technologies
Renaissance Technologies
New York
-$221K
4
SG Americas Securities
SG Americas Securities
New York
-$143K
5
AIM
Alambic Investment Management
California
-$126K
Name Holding Trade Value Shares
Change 		Change in
Stake
CDH
26
Charles D. Hyman
$186K – – –
RJA
27
Raymond James & Associates
Florida
$174K +$118K +1 +100%
Millennium Management
28
Millennium Management
New York
$166K +$235K +2 New
MLICM
29
Metropolitan Life Insurance Company (MetLife)
New York
$159K +$118K +1 New
New York State Common Retirement Fund
30
New York State Common Retirement Fund
New York
$140K – – –
Manulife (Manufacturers Life Insurance)
31
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$136K – – –
HighTower Advisors
32
HighTower Advisors
Illinois
$135K – – –
NFA
33
Nationwide Fund Advisors
Ohio
$134K – – –
CG
34
Cutler Group
California
$120K +$118K +1 New
State Board of Administration of Florida Retirement System
35
State Board of Administration of Florida Retirement System
Florida
$111K – – –
AIG
36
American International Group
New York
$107K – – –
BA
37
BlackRock Advisors
Delaware
$86K – – –
VOYA Investment Management
38
VOYA Investment Management
Georgia
$84K – – –
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
$77K -$353K -3 -75%
ITIM
40
Indiana Trust & Investment Management
Indiana
$77K – – –
HCM
41
Highbridge Capital Management
New York
$74K +$118K +1 New
Cambridge Investment Research Advisors
42
Cambridge Investment Research Advisors
Iowa
$71K – – –
HKIM
43
Hayek Kallen Investment Management
Alabama
$69K – – –
Group One Trading
44
Group One Trading
Illinois
$63K +$118K +1 New
Bank of America
45
Bank of America
North Carolina
$54K – – –
Wells Fargo
46
Wells Fargo
California
$46K -$118K -1 Closed
Legal & General Group
47
Legal & General Group
United Kingdom
$33K – – –
Deutsche Bank
48
Deutsche Bank
Germany
$28K -$235K -2 Closed
Creative Planning
49
Creative Planning
Kansas
$28K – – –
TRCT
50
Tower Research Capital (TRC)
New York
$28K – – –
1
2
3

NVIV Hedge Fund Activity: Q2 2016 in Review

44 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in InVivo Therapeutics Holdings Corp (NVIV) for Q2 2016, worth a combined $44.5M — down 11% from $49.8M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of NVIV and 7 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 12 added.

The largest buyer was Boston Financial Management, opening a new position worth an estimated $470K. The largest seller was Susquehanna International Group, cutting an estimated $353K.

  • 44 institutional investors held InVivo Therapeutics Holdings Corp (NVIV) as of Q2 2016, down from 46 in Q1 2016.
  • Funds reported $44.5M of InVivo Therapeutics Holdings Corp stock for Q2 2016, down 11% quarter-over-quarter.
  • 7 funds opened new InVivo Therapeutics Holdings Corp positions in Q2 2016 and 8 closed out, a net change of -1 holder.
  • The largest InVivo Therapeutics Holdings Corp buyer in Q2 2016 was Boston Financial Management, an estimated $470K added.
  • The largest InVivo Therapeutics Holdings Corp seller in Q2 2016 was Susquehanna International Group, an estimated $353K sold.

Based on aggregated 13F filings for Q2 2016.